Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations

J. Bradley Oldemeyer; Richard J. Lund; Matt Koch; A. John Meares; Robert Dunlay

doi:10.1159/000047304

Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations

J. Bradley Oldemeyer, Richard J. Lund, Matt Koch, A. John Meares, Robert Dunlay

School of Medicine

Research output: Contribution to journal › Article

33 Scopus citations

Abstract

Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.

Original language	English (US)
Pages (from-to)	127-128
Number of pages	2
Journal	Cardiology
Volume	94
Issue number	2
DOIs	https://doi.org/10.1159/000047304
State	Published - Dec 1 2000

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1159/000047304

Fingerprint Dive into the research topics of 'Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations'. Together they form a unique fingerprint.

Cite this

Oldemeyer, J. B., Lund, R. J., Koch, M., Meares, A. J., & Dunlay, R. (2000). Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations. Cardiology, 94(2), 127-128. https://doi.org/10.1159/000047304

@article{715acf8f6293496089d1e0413864bcb6,

title = "Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations",

abstract = "Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.",

author = "Oldemeyer, {J. Bradley} and Lund, {Richard J.} and Matt Koch and Meares, {A. John} and Robert Dunlay",

year = "2000",

month = dec,

day = "1",

doi = "10.1159/000047304",

language = "English (US)",

volume = "94",

pages = "127--128",

journal = "Cardiology",

issn = "0008-6312",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations

AU - Oldemeyer, J. Bradley

AU - Lund, Richard J.

AU - Koch, Matt

AU - Meares, A. John

AU - Dunlay, Robert

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.

AB - Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.

UR - http://www.scopus.com/inward/record.url?scp=0034487393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034487393&partnerID=8YFLogxK

U2 - 10.1159/000047304

DO - 10.1159/000047304

M3 - Article

C2 - 11173785

AN - SCOPUS:0034487393

VL - 94

SP - 127

EP - 128

JO - Cardiology

JF - Cardiology

SN - 0008-6312

IS - 2

ER -